Abstracts

828 – Characterizing Immune Activation in HIV-Exposed but Uninfected Infants in the First Year of Life

Background Successful implementation of perinatal HIV prevention programs has greatly decreased the rate of vertical transmission. Most infants perinatally HIV-exposed are uninfected (HEU). Many health complications have been reported in HEU compared to HIV-unexposed (HUU) infants, including immune dysregulation and increased risk of infection, particularly before 12 months of age. Increased inflammation resulting from in…

1047 – Impact of Doxycycline Postexposure Prophylaxis on Antibiotic Use at a Boston Sexual Health Clinic

Background Doxycycline post-exposure prophylaxis (DPEP) is highly effective at preventing bacterial sexually transmitted infections (STIs) among men who have sex with men and trans women (MSMTW), but its impact on antibiotic prescribing is unclear. We assessed changes in patterns of antibiotic use among MSMTW at a Boston sexual health clinic that implemented DPEP in spring…

863 – Low Rate of Resistance to Dolutegravir in Adolescents Living With HIV-1 in West and Central Africa

Background Achieving good adherence to antiretroviral therapy (ART) and sustaining viral suppression remain challenging in adolescents living with HIV (ALHIV). However, since the large-scale rollout of dolutegravir (DTG)-based ART in pediatrics, few data are available on ART outcomes in ALHIV, particularly in West and Central Africa. We sought to evaluate the rate of virological failure (VF)…

338 – Single-Genome Profiling of Promoter DNA Methylation Signatures in Intact HIV-1 Proviruses

Background DNA methylations located near promoter region and transcription start site of HIV proviral sequence silence proviral expression in in vitro latency models, but their roles for HIV persistence and expression in vivo remain elusive. Investigating DNA methylation profiles of participant-derived single intact proviruses will help evaluate evolutionary dynamics of reservoir cells. Methods We used REC-Seq…

386 – Metformin Over 2 Years Shows No Effect on the HIV Reservoir in PWH on ART Without Diabetes

Background In the LILAC pilot trial, 12 weeks of metformin reduced colon CD4+ T-cell infiltration, mTOR activation, and potentially HIV transcription in a subset of ART-suppressed PWH. We investigated whether long-term metformin could affect HIV reservoirs in non-diabetic PWH. Methods The MetforAging trial (EudraCT: 2021-003299-15) is a 96-week, randomized, double-blind, placebo-controlled study designed to assess…

948 – Association of Substance Use Disorder With Viral Suppression in South Carolina Counties

Background While it is well known that substance use disorder (SUD) negatively affects HIV outcomes, most research has focused on individual-level dynamics, overlooking the role of broader influences of SUD prevalence on HIV outcomes. Assessing SUD rates at the county level provides a structural lens for understanding how geographic and contextual factors associate with HIV…

982 – Adherence and Persistence in US Real-World New PrEP Users: Cabotegravir (CAB-LA) vs Oral PrEP

Background Cabotegravir long-acting (CAB-LA) was approved by the United States Food and Drug Administration for human immunodeficiency virus 1 (HIV-1) pre-exposure prophylaxis (PrEP) in December 2021. This PrEPFACTS analysis evaluated real-world adherence and persistence patterns for CAB-LA compared to oral PrEP in new PrEP initiators. Methods PrEPFACTS was a retrospective US cohort study using data from…

635 – Structural Deletions in HTLV-1 Proviruses Correlate With Disease Severity in Adult T-Cell Leukemia

Background HTLV-1 is a neglected retrovirus associated with severe neurological and lymphoproliferative diseases, including tropical spastic paraparesis/HTLV-1-associated myelopathy (HAM/TSP) and adult T-cell leukemia/lymphoma (ATLL). Although Spain is a non-endemic country, more than 550 individuals with HTLV-1 infection had been reported up to date. A national HTLV-1 registry has existed since 1989. Most cases are migrants…